The place of new antibiotics for Gram-negative bacterial infections in intensive care: report of a consensus conference.
Dequin PF, Aubron C, Faure H, Garot D, Guillot M, Hamzaoui O, Lemiale V, Maizel J, Mootien JY, Osman D, Simon M, Thille AW, Vinsonneau C, Kuteifan K.
Dequin PF, et al.
Ann Intensive Care. 2023 Jul 4;13(1):59. doi: 10.1186/s13613-023-01155-4.
Ann Intensive Care. 2023.
PMID: 37400647
Free PMC article.
Review.
METHODS: An ad hoc committee without any conflict of interest (CoI) with the subject identified the molecules (ceftolozane-tazobactam, ceftazidime-avibactam, imipenem-cilastatin-relebactam, meropenem-vaborbactam and cefiderocol); defined 6 generic questions; drew up a list …
METHODS: An ad hoc committee without any conflict of interest (CoI) with the subject identified the molecules (ceftolozane-tazobactam, cefta …